| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 06/19/2013 | EP2603496A1 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds |
| 06/19/2013 | EP2603491A1 Process for the preparation of enantiomeric forms of 2,3-diaminopropionic acid derivatives |
| 06/19/2013 | EP2603490A1 Novel trpv3 modulators |
| 06/19/2013 | CN103168033A Quinazoline compounds as sodium channel blockers |
| 06/19/2013 | CN103159685A Preparation method of 4-chloro-6, 7-di(2-methoxyl ethoxyl) quinazoline |
| 06/19/2013 | CN103159684A Method for preparing 2-amino-4, 6-dimethoxypyrimidine |
| 06/19/2013 | CN103159683A Method of chirality volution phosphoric acid catalysis preparing optical activity dihydro-pyrimidone derivative |
| 06/19/2013 | CN103159646A Hydroxamic acid compound, and preparation method and application thereof |
| 06/19/2013 | CN102295609B 2-[(substituted phenylamino)carbonyl methylthio]-6-cyclohexylmethyl-3H-pyrimidine-4-ketone compounds, synthetic method thereof and purpose thereof |
| 06/19/2013 | CN101107234B HIV inhibiting 2-(4-cyanophenylamino) pyrimidine derivatives |
| 06/19/2013 | CN101065359B Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery |
| 06/18/2013 | US8466165 4-phenylamino-quinazolin-6-yl-amides |
| 06/18/2013 | US8466162 5-alkynyl-pyridines |
| 06/18/2013 | US8466155 Pyrimidines |
| 06/13/2013 | WO2013086229A1 Bicyclic aryl and heteroaryl sodium channel inhibitors |
| 06/13/2013 | WO2013086208A1 Substituted pyrimidinone-phenyl-pyrimidinyl compounds |
| 06/13/2013 | WO2013084013A1 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists |
| 06/13/2013 | WO2013054147A3 Erlotinib salts |
| 06/13/2013 | US20130150579 NOVEL INTERMEDIATES FOR THE PREPARATION OF HMG-CoA REDUCTASE INHIBITORS |
| 06/13/2013 | US20130150392 Iminopropene compound and use thereof |
| 06/13/2013 | US20130150390 Therapeutic or prophylactic agent for allergic dermatitis |
| 06/13/2013 | US20130150388 Inhibitors of nedd8-activating enzyme |
| 06/13/2013 | US20130150387 Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture |
| 06/13/2013 | US20130150365 Insecticidal Triazines and Pyrimidines |
| 06/13/2013 | US20130150358 Theramutein modulators |
| 06/13/2013 | US20130150356 Acyl Piperazine Derivatives as TTX-S Blockers |
| 06/13/2013 | US20130150349 2,4-pyrimidinediamine compounds and their uses |
| 06/13/2013 | CA2857198A1 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists |
| 06/12/2013 | EP2602250A1 Method for preparing rosuvastatin calcium intermediate |
| 06/12/2013 | EP2602249A1 Synthesis of rosuvastatin by means of co-crystals |
| 06/12/2013 | EP2601950A1 Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists |
| 06/12/2013 | EP2601178A2 Salts of lapatinib |
| 06/12/2013 | CN1668305B Microbicidal pyrimidine or triazine for preventing sexual HIV transmission |
| 06/12/2013 | CN103155201A Light-emitting element, light-emitting device, electronic device, lighting device, and novel organic compound |
| 06/12/2013 | CN103153971A Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol |
| 06/12/2013 | CN103153964A Process for preparing bosentan monohydrate and its intermediates |
| 06/12/2013 | CN103153963A Cyclopropane compound |
| 06/12/2013 | CN103153945A 1-hydroxyimino-3-phenyl-propanes |
| 06/12/2013 | CN103153917A Thionation process and thionating agent |
| 06/12/2013 | CN103145629A Synthetic process of tandutinib for treating solid tumors |
| 06/12/2013 | CN103145628A Erlotinib-hydrate crystal form I preparation method |
| 06/12/2013 | CN103145627A Azoxystrobin synthesis method |
| 06/12/2013 | CN103145626A Method for synthesizing 4-amino-2-(methylmercapto) pyrimidine-5-formaldehyde |
| 06/12/2013 | CN103145625A Method for preparing 2-cyanopyrimidine |
| 06/12/2013 | CN103145624A Molecular glass positive photoresist and patterning method thereof |
| 06/12/2013 | CN101932565B Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor |
| 06/12/2013 | CN101918370B Compound for organic electroluminescent device and organic electroluminescent device using the same |
| 06/12/2013 | CN101573333B Inhibitors of histone deacetylase |
| 06/12/2013 | CN101490015B 瑞舒伐他汀锌盐 Rosuvastatin zinc |
| 06/11/2013 | US8461167 Acetylenic heteroaryl compounds |
| 06/11/2013 | US8461166 Anilinoquinazolinyl amide derivatives; radiolabels as bioprobes for Positron Emission Tomography and Single Photon Emission Computed Tomography, and as radiopharmaceuticals for radiotherapy; improved solubility, bioavailability, biostability |
| 06/11/2013 | US8461160 Dihydropyrimidinones |
| 06/11/2013 | US8461147 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation |
| 06/11/2013 | CA2683826C Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials |
| 06/11/2013 | CA2581516C Quinazoline derivatives |
| 06/11/2013 | CA2546101C N-acylsulfonamide apoptosis promoters |
| 06/06/2013 | WO2013081087A1 Method for preparing optically active compound |
| 06/06/2013 | WO2013080999A1 Agent for inhibiting expression of npc1l1 and/or lipg mrna and agent for preventing and/or treating obesity |
| 06/06/2013 | WO2013079578A1 Production of 18f- labelled compounds comprising hydrolytic deprotection step and solid phase extraction |
| 06/06/2013 | WO2013079494A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | US20130143908 Method for preparing rosuvastatin calcium intermediate |
| 06/06/2013 | US20130143906 Substituted pyrimidinone-phenyl-pyrimidinyl compounds |
| 06/06/2013 | US20130143890 Co-crystal intermediates of rosuvastatin and methods of using same |
| 06/06/2013 | US20130143865 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 06/06/2013 | US20130142807 Compositions and methods for inhibition of the jak pathway |
| 06/06/2013 | CA2857645A1 Assays, antibodies, immunogens and compositions related to 5-fu |
| 06/06/2013 | CA2856457A1 Production of 18f- labelled compounds comprising hydrolytic deprotection step and solid phase extraction |
| 06/06/2013 | CA2850593A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | CA2797350A1 Co-crystal intermediates of rosuvastatin and methods of using same |
| 06/05/2013 | EP2599386A1 2-aminopyrimidine modulators of the histamine h4 receptor |
| 06/05/2013 | EP2598492A1 Bicyclic azaheterocyclic carboxamides as inhibitors of the kinase p70s6k |
| 06/05/2013 | EP2598484A1 Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof |
| 06/05/2013 | EP2598482A1 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use |
| 06/05/2013 | EP2598481A1 Sulfonamide compounds useful as cyp17 inhibitors |
| 06/05/2013 | EP2598480A1 Cyclopropylamine derivatives useful as lsd1 inhibitors |
| 06/05/2013 | CN103140480A Heterocyclic compounds, their preparation and their therapeutic application |
| 06/05/2013 | CN103140479A Manufacturing process for pyrimidine derivatives |
| 06/05/2013 | CN103140476A Novel trpv3 modulators |
| 06/05/2013 | CN103140474A Napht- 2 -ylacetic acid derivatives to treat aids |
| 06/05/2013 | CN103140221A Novel heterocyclic derivatives and pharmaceutical composition containing same |
| 06/05/2013 | CN103130788A Pyrimidine amide compound, and preparation method, anti-HIV activity and anti-TMV activity thereof |
| 06/05/2013 | CN103130787A Pyrimidone amide compound, and preparation method, anti-HIV activity and anti-TMV activity thereof |
| 06/05/2013 | CN103130730A Novel quinazoline derivative, and preparation method, anti-HIV activity and anti-TMV activity thereof |
| 06/05/2013 | CN103130729A Preparation method of 4-chloro-7-methoxyl quinazoline-6-alchol acetate |
| 06/05/2013 | CN103130728A Preparation method of 5-fluorouracil-1-methanal |
| 06/05/2013 | CN103130727A Preparation method of saflufenacil intermediate |
| 06/05/2013 | CN103130726A Preparation method of Ticagrelor intermediate 4,6-dichloro-2-(pyridinecarboxylic)-5- aminopyrimidine |
| 06/05/2013 | CN103130725A Novel crystal form of (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl (methylsulfonyl) amino] pyrimidin-5-yl] (3R, 5S)-3, 5-dihydroxy-heptyl-6-olefine acid and compound thereof |
| 06/05/2013 | CN103130724A Organic semiconductor material containing naphthyl anthracene, preparation method and application thereof |
| 06/05/2013 | CN102304091B Emodin and fluorouracil combined compound having antitumor activity and preparation method thereof |
| 06/05/2013 | CN101918373B Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 06/05/2013 | CN101821229B Tricyclic amine compound |
| 06/05/2013 | CN101619043B Quinazoline derivant and medical application thereof |
| 06/04/2013 | US8455661 Catalysts containing N-heterocyclic carbenes for enantioselective synthesis |
| 06/04/2013 | US8455640 Process for statins and its pharmaceutically acceptable salts thereof |
| 06/04/2013 | US8455639 Crystalline form of an organic compound |
| 06/04/2013 | US8455500 3-hydroxy-5-arylisoxazole derivative |
| 06/04/2013 | US8455499 Alkyne antagonists of lysophosphatidic acid receptors |
| 06/04/2013 | US8455498 Inhibitors of histone deacetylase |
| 06/04/2013 | US8455490 Facially amphiphilic polymers and oligomers and uses thereof |